CEA ISAC

N/A

Report date: 2025/05/21 15:15:29

Base Information

Drug NameCEA ISAC

Drug Alias NameCEA ISAC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linker

Mechanisms of ActionAnti-CEACAM5Toll like receptor 7 agonistsToll like receptor 8 agonists

TargetsCarcinoembryonic antigen related cell adhesion molecule 5Toll like receptor 7Toll like receptor 8

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBolt Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBolt Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A